A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

NCT01285466 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic or Locally Advanced Solid Tumors

Interventions

DRUG: BEZ235 + paclitaxel
DRUG: BKM120 + paclitaxel
DRUG: BEZ235 + paclitaxel + trastuzumab
DRUG: BKM120 + paclitaxel + trastuzumab

Sponsor

Novartis Pharmaceuticals